Real-World Application of Anti-β-Amyloid Monoclonal Antibodies : Untangling Eligibility
| Errataetall: |
CommentOn: Neurology. 2023 Nov 7;101(19):e1837-e1849. - PMID 37586881 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:101 |
|---|---|
| Enthalten in: |
Neurology - 101(2023), 19 vom: 07. Nov., Seite 811-812 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Howe, Matthew D [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 08.11.2023 Date Revised 12.12.2023 published: Print-Electronic CommentOn: Neurology. 2023 Nov 7;101(19):e1837-e1849. - PMID 37586881 Citation Status MEDLINE |
|---|
| doi: |
10.1212/WNL.0000000000207873 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360860745 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360860745 | ||
| 003 | DE-627 | ||
| 005 | 20231227131456.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1212/WNL.0000000000207873 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1225.xml |
| 035 | |a (DE-627)NLM360860745 | ||
| 035 | |a (NLM)37586880 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Howe, Matthew D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Real-World Application of Anti-β-Amyloid Monoclonal Antibodies |b Untangling Eligibility |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.11.2023 | ||
| 500 | |a Date Revised 12.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Neurology. 2023 Nov 7;101(19):e1837-e1849. - PMID 37586881 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Amyloid beta-Peptides |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 700 | 1 | |a Rabinovici, Gil D |e verfasserin |4 aut | |
| 700 | 1 | |a Salloway, Stephen P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neurology |d 1951 |g 101(2023), 19 vom: 07. Nov., Seite 811-812 |w (DE-627)NLM000034355 |x 1526-632X |7 nnns |
| 773 | 1 | 8 | |g volume:101 |g year:2023 |g number:19 |g day:07 |g month:11 |g pages:811-812 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1212/WNL.0000000000207873 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 101 |j 2023 |e 19 |b 07 |c 11 |h 811-812 | ||